Larry C. Deeb, MD

Larry C. Deeb, M.D.
Pediatric Endocrinologist




Emory University. Atlanta, GA BA
1965-69 History


Emory University, Atlanta, GA MD
1969-73 Medicine


University of Minnesota, Minneapolis, MN
Peds Res 1973-75 Pediatrics


University of Minnesota, Minneapolis, MN
Peds Endo 1975-77 Peds Endo




Medical Director: Diabetes Center at
Tallahassee Memorial Hospital
1221 Hodges Drive
Tallahassee, Fl 32308

Head: Epidemiology and Statistics Group
Diabetes Control Activity
Centers for Disease Control, Atlanta, GA

Epidemic Intelligence Service Officer
Diabetes Control Activity
Centers for Disease Control, Atlanta, GA

Private Practice
Larry C. Deeb, M.D., P.A.
2804 Remington Green Circle
Tallahassee, FL 32308



Clinical Professor, 1993-
Associate Clinical Professor, 1988-93
Clinical Assistant Professor, 1981-88
Department of Pediatrics


College of Medicine
University of Florida


Research Associate, 1987-
Center for the Study of Populations
Florida State University


Associate in Medicine, 1993-
College of Medicine
Florida State University

Courtesy Associate Professor, Behavioral Medicine, 2004-6
Courtesy Professor, Behavioral Medicine, 2007-
Courtesy Assistant Professor, Pediatrics, 2004-
Florida State University2004-2010

American Diabetes Association


Programs Committee, 1984-5

Chair, Council on Health Care Delivery and
Public Health 1986-87

Chair, Committee on Affiliate Education and
Program Services, 1986-87

Task Force on Epidemiology and Statistics 1988-1989

 Publications Committee, 1989-91

 Board of Directors, 1990-93

 Chair, Non-Periodicals Review Panel, 1991-93

 Chair Elect, Council on Clinical Endocrinology, 1992-94

 Member Nominating Committee 1993-5

 Chair, Council on Clinical Endocrinology and Metabolism, 1994-96

 Chair, Council on Diabetes in Youth,1996-97

 Publications Policy Committee, 1996-97

 Chair, Publications Policy Committee, 1997-2000

 Member, Diabetes Quality Improvement Committee,1998-2000

 Member, Provider Recognition Committee, 2000-01

 Member Finance Committee, 2002-04

 Vice President, 2004-05

 President-Elect, 2005-2006

 President, Medicine and Science 2006-07

Co-Chair Working Groupon Safe at Schools



Deeb, L.C. Tan, M.H. and Alberti, K.G.M.M., Insulin Availability among IDF Member Associations: Report of the Task Force on Insulin Distribution, Diabetes Care,
1994; 17: 220-223.

Will JC. German RR. Schuman E. Michael S. Kurth DM and Deeb L.C, Patient adheraence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study.  American Journal of Public Health. 1994; 84(10): 1669-71.

Mazze, R.S., Etzwiler, D., Strock, E., Peterson, K.A., McClave, C.R., Meszaros, J.F., Leigh, C., Owens, L.W., Deeb, L.C., Peterson, A. Kummer, M., Staged Diabetes Management: Towards an Integrated Model of Diabetes Care, Diabetes Care 17 (Suppl. 1) 56-66.1994.

Edelman SV, Callahan P, Deeb LC.Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).Diabetes Technol Ther. 2000 Summer; 2(2):233-8.

Deeb, LC, Holcombe JH, Brunelle R, Zalani S, Brinks, Jenner M, Kitson H, Perlman K and Spencer M,I insulin lispro lowers postprandial glucose in prepubertal children with diabetes.
Pediatrics. 2001 Nov; 108(5): 1175-9.

Macaluso, CJ, Bauer, UE, Deeb, LC, Malone, JI, Chaudhari, M, Silverstein, J, Eidson, M, Goldberg, RB, Gaughan-Bailey, B, Brooks, RG, Rosenbloom, AL, Type 2 diabetes mellitus among Florida children and adolescents, 1994 through 1998, Public Health Reports,2002, Jul/Aug, 373-9.

Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M,Anderson B, Holzmeister LA, Clark N: Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association (ADA Statement). Diabetes Care 28:186–212, 2005

Bangstad HJ, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R; International Society for Pediatric and Adolescent Diabetes(ISPAD). Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007. Pediatr Diabetes. 2007 Apr;8(2):88-102.

Johnson SB, Pilkington LL, Deeb LC, Jeffers S, He J, Lamp C. Prevalence of overweight in north Florida elementary and middle school children: effects of age, sex, ethnicity, and socioeconomic status.J Sch Health. 2007 Nov;77(9):630-6.

Deeb LC. Diabetes technology during the past 30 years: a lot of changes and mostly for the better. Diabetes Spectrum. 2008; 21: 78-83.

Driscoll, KA, Johnson, Suzanne bennett, Barker, D, Quittner, L, Deeb, LC Geller, DE, Gondor, M, Silverstein, JH. Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosis. Journal of Pediatric Psychology, 201035,: 814-22.

Aansstoot, HJ, Anderson, B, Dianne,T, Deeb, L, Green, A, Kaufman, F, Lange, K, Ostergren, N, Peyrot, M, Rosenfeld, K, Hitchcock, J, Jackson, C, and deWit, M. Outcomes of the DAWN Youth Summits of 2007 and 2008, Pediatric Diabetes, 2009 (10) suppl 13, 21-27.

Lange,K, Jackson,C,  Deeb,L , Diabetes care in schools--the disturbing facts, Pediatric Diabetes, 2009 (10) suppl 13, 28-36.

Driscoll KA, Johnson SB, Tang Y, Yang F, Deeb LC, Silverstein J. Does blood glucose monitoring increase prior to clinic visits in children with type 1 diabetes  Diabetes Care. 2011 Aug 18. [Epub ahead of print] PMID: 21852678.

Bolli GB, Deeb LC, Garg SK, Leahy JL, Mazze RS, Owens DR, Riddle MC, Southerland P, Strock ES. International forum for the advancement of diabetes research and care, April 29-3-, Athens Greece; Diabetes Technol Ther. 2011 Sept;13(9):967-79.

Deeb LC, Parkes JL, Pardo S, Schachner HC, Viggiani MT, Wallace J, Bailey T. Performance of the DIDGET blood glucose monitoring system in children, teens and young adults, J Diabetes Sci Technol. 2011 Sep 1;5(5): 1157-63.

Clarke W, Deeb LC, Jameson P, Kaufman F, Klingensmith G, Schatz D, Silverstein JH, Siminerio LM. Diabetes care in the school and day care setting Diabetes Care. 1012 Jan;35 Suppl 1:S76-80. No abstract available.



Eli Lilly, 1995-6: Lispro insulin in Prepubertal Children with Diabetes: Double crossover trial; senior investigator, enrolled 10 of 60 children in trial; no dropouts. John Holcombe, MD. Eli Lilly


Pfizer, Inhaled Insulin in Adolescents, 1998-2004: Followed 9 children for over 4 years on inhaled insulin; no dropouts in investigation; 9 of 10 participated until Pfizer ended trial. Lead physician no longer with Pfizer.


MAPI Values, Evaluation and Validation of a new quality of life instrument in children with diabetes, 2001: Enrolled 50 children in 4 weeks to validate instrument


Pfizer, Inhaled Insulin in Preadolescents, 1999-2003: Enrolled 10 children all completed clinical trial, 9 completed nearly 3 years of follow-up until Pfizer ended trial. Lead physician no longer with Pfizer.


Novo Nordisk, Family Preference for Growth Hormone Delivery Systems, 2000-2001. Second highest enroller in 20-center trial; all completed. George Bright, MD, currently with Tercica.


NovoNordisk, Novolog Vs Humalog in Children using insulin pumps, 2005 Second highest enroller in multicenter trial; all completed. Campbell Howard, MD, Novo Nordisk


NIH Ro1DK59626-01 HANDling Diabetes Project, 2002-2007: When Dr. Suzanne Johnson relocated to FSU College of Medicine transferred grant. We enrolled 50 children to keep grant on schedule to finish data collection by Aug 2007. No dropouts.

Bayer, Evaluation of accuracy of Didgit Glucose meter, 2009 evaluated 150 children with diabetes using new meter

Abbott, Evaluation of Freestyle meters in small children, 2010, evaluated use of meters in use by young children

NovoNordisk, insulin degludec in children 1 to 18; use of new long acting insulin in children from 1-18